We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Arix Bioscience Plc | LSE:ARIX | London | Ordinary Share | GB00BD045071 | ORD 0.001P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 142.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
08/4/2022 07:18 | But what will they do with that cash? Some was used to buy back shares much higher. Will they "invest" the rest better than they have done so far? SENS this morning is British biotech in a nutshell. £1.50 a few months ago, 1.2p today. | stockstockham | |
07/4/2022 23:27 | You could argue Arix is already "insanely cheap" with 95-100p of cash on its balance sheet. If this sector does keep tanking Arix will probably be one of the winners. | hugepants | |
06/4/2022 13:54 | Yes, that's my opinion. This will be a buy when it and the sector looks insanely cheap and no one is interested. I would guess once rates top and then a period of consolidation. | hpcg | |
06/4/2022 10:17 | Hmm...doesn't look pretty - another leg down perhaps... free stock charts from uk.advfn.com | skyship | |
05/4/2022 20:19 | More disappointing news from an investee company (Imara) Excluding Aura which is actually up, the listed portfolio looks like its down about 40% year to date. And last year was pretty awful as well. | hugepants | |
04/4/2022 11:41 | Anyone know when the results are coming out? | novision | |
07/3/2022 09:48 | This remains on my watchlist as it could well reach a Graham type value proposition. | hpcg | |
26/2/2022 11:40 | The indicators moving up as the share price once again holds the line at 120p. Perhaps one institution building a small position secure in the knowledge that this is a safe BioTech play due to the c35% NAV discount (to ST's 185p estimate) and much of that NAV still in CASH. free stock charts from uk.advfn.com | skyship | |
18/2/2022 13:07 | Would have been nice to have done the buy backs at this price! Waiting game here. I topped up at 140 thinking that was near the bottom if I recall correctly. The fundamentals here and the double bottom formed could mean a nice move up to 140 plus in double quick time. I'm an optimist but you need to be in these markets! | pinemartin9 | |
18/2/2022 13:05 | Yes. Arix has net cash of around £127.8mn (99p a share) after accounting for £30mn of investments made in the second half of 2021, estimated operating expenses of £2.5mn during the six-month period, and £3.5mn of share buybacks. This means that the cash pile backs up 83 per cent of the company’s £154mn market capitalisation, so the unlisted and listed portfolios are in the price for only £26mn even though they have a combined value of £111mn. | ohisay | |
18/2/2022 08:48 | He estimates the current NAV at 185p. So at 123p the discount = 33.5%. | skyship | |
18/2/2022 08:42 | A few small buys this morning after ST reiterates his BUY recommendation in a Review of his Bargains 2021 portfolio. Closing para see below: ==================== Priced for a positive outcome The bottom line is that cash in the bank and the valuable Artios stake back up all of Arix’s market capitalisation of £154mn, so you are getting a free ride on the whole listed portfolio worth £51mn and £35mn of other unlisted holdings, too. The de-rating has gone too far, and bottom fishers should be rewarded. Buy. | skyship | |
12/2/2022 13:59 | Are they really going to drum roll until March to reveal how their NAV is doing? | riskonricky | |
03/2/2022 02:50 | I haven't changed my view that it would be useful for them ..and potential investors if they released an updated NAV at the end of every month . | ohisay | |
02/2/2022 22:08 | Mid/smll US bio has taken a proper beating over last 12mnths. Just take a look at the XBI: | rambutan2 | |
02/2/2022 14:41 | Does show the risks in biotech. LogicBio was trading at $15 just 3yrs ago - now down at $1... | skyship | |
02/2/2022 14:37 | Re today's RNS: As of close of business on 1 February 2022 Arix held 2,716,211 shares in LogicBio. So a $4m investment has lost a third down to $2.6m. So bad news for LogicBio - but really neither here nor there for ARIX! Hence price reaction muted... | skyship | |
28/1/2022 19:37 | Rofl, yeah, just a shame about IMRA, LOGC, AUTL, HARP... oh and SIGHT | riskonricky | |
28/1/2022 16:17 | Ah - thnx; I as looking through our various holdings! Aura incidentally holding up quite well @ $17.80 | skyship | |
28/1/2022 15:23 | Russell 2000 | hpcg | |
28/1/2022 14:01 | hpcg - RUT? | skyship | |
28/1/2022 13:15 | I trust in his integrity so not really bothered when Sky posts ..shrug | badtime | |
28/1/2022 12:01 | Market is all wrong for Arix right now IMO. Its listed holdings will keep getting battered. Need to see RUT bottom, which it is a long way from doing. | hpcg | |
28/1/2022 10:23 | Usually always do....and have just done so for the purchase - also see post Nos.304/358 & 364 - and perhaps more further back. So get off your high horse! | skyship |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions